This site is intended for healthcare professionals
Search

Find disease awareness content and relevant supporting materials

Learning Zone 309 Events 33 News 17673 Drugs 72300 Trials 8191 Guidelines 690 Journals 3582
Filter results
Sort by:
Relevance
to
Clinical trials
Clinical trial
02/04/14

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator (TEMPO)

This study is to evaluate the effect of GS-6615 compared to placebo on the overall occurrence of appropriate implantable cardioverter-defibrillator...

  • 1 min read
  • Source: Clinicaltrials.gov
Latest drug news
News
20/12/21

FDA approves next generation Gallan implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. Abbott

Abbott announced that the FDA has approved the company's next-generation Gallan™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices.

  • 1 min read
Latest drug news
Drug news
12/05/17

FDA approves Resonate family of implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator systems with longer life batteries.- Boston Scientific

Boston Scientific has received FDA approval for the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator...

  • 1 min read
Latest drug news
Drug news
26/09/17

Launch of the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems featuring the HeartLogic Heart Failure Diagnostic for heart failure management.- Boston Scientific.

Boston Scientific has launched the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems featuring...

  • 1 min read
Latest drug news
Drug news
12/08/18

Medtronic initiates pilot study for the Extravascular Implantable Cardioverter Defibrillator .

Medtronic plc has announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system,...

  • 1 min read
Latest drug news
Drug news
19/05/15

Medtronic Evera MRI SureScan implantable cardioverter defibrillator unaffected by MRI scans-Medtronic

Medtronic plc announced clinical trial results for the Medtronic Evera MRI SureScan implantable cardioverter defibrillator (ICD) following MRI scans. The...

  • 1 min read
Latest drug news
Drug news
17/04/12

Ellipse Cardioverter Defibrillator ( St Jude) receives CE Mark

CE Mark approval has been granted for the Ellipse implantable cardioverter defibrillator (ICD)from st Jude Medical. Designed with feedback from...

  • 1 min read
Clinical trials
Clinical trial
22/01/14

Automate Detection of Sleep Apnea by ApneascanTM (AIRLESS)

The purpose of the study is to compare, three months after implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D), the...

  • 1 min read
  • Source: Clinicaltrials.gov
News
20/12/21

CE Mark for Gallant implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator devices.- Abbott

  • 1 min read
Latest drug news
Drug news
11/05/12

Lumax 740 defibrillator (Biotronik) is FDA approved

Biotronik has received FDA approval of its new Lumax 740 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds)....

  • 1 min read
See more